When The Diagnosis Is MSUD, Every Minute Counts | Stories | PerkinElmer
珀金埃尔默网站上的Cookie
珀金埃尔默使用cookies来确保我们为您提供在我们网站上的最佳体验。 这可能包括来自第三方网站的cookies。 如果您不改变您的设置点击继续,我们会认为您同意接收本网站的cookies。 您可以随时更改您的Cookie设置。 要了解更多信息,请查看我们的Cookie政策,其中包含有关如何管理Cookie的信息。

When The Diagnosis Is MSUD, Every Minute Counts

June 24, 2015

When The Diagnosis Is MSUD, Every Minute Counts

An Inherited Metabolism Disorder

What a difference a day makes. For a baby boy in Bengaluru, India, that day in December, 2014, ticked off the hours between a life that would likely be spent suffering from neurological disorders and a normal, healthy childhood.

When the baby’s parents brought the infant to the hospital, he was already in poor condition. He was lethargic and had trouble breathing. Initially diagnosed as “neurologically drowsy,” he was admitted into the Sick Newborn Care Unit (SNBC) and placed on a respirator. Soon after his arrival in the SNCU, the baby received a blood test on orders from a metabolic specialist on staff. Getting the results from that test led to be a nerve-wrecking race against the clock that would eventually save the little boy’s life.

Maple Syrup Urine Disorder

The baby’s blood test came back positive for Maple Syrup Urine Disorder (MSUD), so named because of the sweet odor of untreated babies’ urine. To treat the disorder, the baby was immediately placed on a special supplemental formula. Instead of improving, he lapsed into a coma – one of the classic symptoms of severe MSUD.

Despite the maple syrup analogy, there is nothing sweet about MSUD, also known as branched-chain alpha-ketoacid dehydrogenase deficiency. (Reference: Maple Syrup Urine Disease (MSUD), Healthline) Appearing in one of every 185,000 births globally, this rare genetic disorder occurs when the body lacks special enzymes to break down certain amino acids. (Reference: Maple Syrup Urine Disorder; MSUD, Online Mendelian Inheritance in Man, Johns Hopkins University) The result is an accumulation of keto acids that lead to a variety of dangerous symptoms, from seizures and neurological disorders to coma, and death. Varying forms of the disease may be milder, but even those symptoms can often flare up in times of illness or stress to cause a major metabolic crisis. (Reference: Maple Syrup Urine Disease, WebMD)

An International Network Of Healers

With their baby now in a coma, his parents went on line in a desperate bid to find anyone who could help them. Incredibly, they located another Indian couple living in the U.S. whose baby was also born in India with MSUDs. After sharing stories, both couples realized that neither infant was screened at birth for the genetic disorder. The American couple then quickly reached out to an extended MSUD support network in the U.S. with dramatic results. Dr. Kevin A. Strauss, Medical Director at the Clinic for Special Children in Strasburg, PA, responded to the urgent request.

At the same time, Mandeep Singh, Market Development Leader - Screening Systems, South Asia for PerkinElmer, based in New Delhi, India, learned of the dire situation more than 2,000 km away. Singh knew that sending a blood sample to the U.S. would take too long, so he contacted his sales manager for the Bangaluru area, Manjunath Bhat for help. Bhat immediately collected a blood sample and hand delivered it to a PerkinElmer customer, Acuity Labs, which specializes in prognostic healthcare. Within hours Acuity sent the test results to Dr. Strauss in the U.S. Dr. Strauss then called the Bengaluru medical team and provided a new formula for a modified nutritional supplement for the little newborn. Slowly, the infant emerged from his coma. All of this activity took place in a single day.

Within a few weeks, the little boy was back home with his grateful parents. Thanks to some fact-acting international cooperation and PerkinElmer’s Newborn Screening Systems, he will now be able to lead a long and healthy life with proper treatment for his congenital disorder.

The Importance Of Newborn Screening

While newborn screening is common in the U.S. and other countries, the number of diseases that are screened varies widely around the globe. Many other parts of the world, including India, do not have mandatory newborn screening programs at all, largely because of cost. (Reference: Newborn Screening in India: Current Perspectives, Indian Pediatrics)

Thanks to companies such as PerkinElmer, a global leader in newborn screening services, inexpensive screening tests for newborns are growing in popularity around the world. Throughout Asia, for instance, government, medical centers, and company officials are working together towards the goal of screening all newborns as part of a global public health initiative… one heel prick at a time.


更多故事关于 新闻, 新生儿筛查, 诊断

珀金埃尔默携生物大分子制药方案亮相2018生物制品年会

中国生物制品年会作为学界一年一度最重要的活动,引起了广泛的行业关注。今年生物制品年会于11月15-16日在气候宜人的“春城”昆明举行,本次活动围绕“新型生物技术药研发与评价”、“新型疫苗研发与评价”、“基因与细胞治疗研发与评价”、“生物制药投融资”、“生物制药工程与数字信息化”展开,为2000余位参会代表带来近100场主...

珀金埃尔默在analytica China 2018上载誉归来

经过三天的热闹与相聚,慕尼黑(上海)生化分析展于11月2日落下帷幕。珀金埃尔默展出的仪器覆盖原子光谱、色谱、材料表征、联用技术、生命科学等产品线。除此之外,还有众多行业解决方案、OneSource一站式实验室服务、试剂与耗材等配套服务。

感谢有你——再聚慕尼黑分析生化展

此次珀金埃尔默在慕尼黑生化展上展出了ICP-MS NexIon 2000, ICP-OES Avio 500,高内涵分析系统Operetta CLS及新品荧光分光光度计FL 6500等共计10余台仪器。

珀金埃尔默推出QSight®400系列三重四极杆质谱仪

美国拉斯维加斯大麻商业展览会——致力于创建更健康世界的全球领先企业珀金埃尔默日前宣布推出QSight®400系列三重四极杆质谱仪。这是一款高灵敏度分析仪器,专门用于快速测定和定量复杂食品、大麻和环境测试中的杀虫剂、真菌毒素和新型污染物。

历久弥新珀金埃尔默发布两款质谱新品,闪耀中国质谱学术大会

2018年中国质谱学术大会(CMSC 2018)在广州东方宾馆隆重开幕。来自十多个国家地区的质谱技术与应用方面的专家学者、厂商及相关用户共1900余人参加了本次会议。珀金埃尔默作为本次大会的白金赞助商,全程倾情参与了此次大会。

Related Products